Tharimmune

Biotechnology company(THAR)

關於 Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
社群
Website
標簽
Digital Asset Treasury
Publicly listed company
Crypto Stocks

熱度值變化趨勢

暫無數據

團隊成員

Mark Wendland
Mark Wendland

Chairman and CEO

Angela Radkowski
Angela Radkowski

COO

投資方

Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest

投融資詳情

Post-IPO(2025-11-03)
金額$170.85億
投資方
Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest
估值--